Status:
RECRUITING
Dexmedetomidine Use in SZMN Blocks for Pediatric T&A Pain Control
Lead Sponsor:
Stanford University
Conditions:
Postoperative Pain
Opioid Use
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
The suprazygomatic maxillary nerve (SZMN) block is a well-established, safe and effective regional technique for pain management following cleft palate procedures. However, it has not been studied for...
Detailed Description
Patients between 6 months and 18 years undergoing T\&A surgical procedures will be reviewed for potential study enrollment. If participants agree to participate, they will be randomized into one of th...
Eligibility Criteria
Inclusion
- Ages 6 months - 18 years
- Give consent/parental consent to participate in study
- Patients undergoing tonsillectomy and adenoidectomy
Exclusion
- Participants who do not consent or have parental consent
- Patients who require urgent/emergent intervention
- Patients who undergo additional combined surgical procedures with separate incisions (in addition to the adenotonsillectomy)
- Patients with known difficult airway, clinical hemodynamic instability, coagulopathy, chronic pain history, chronic pain medication use, and unrepaired congenital heart disease
- Patients under age 6 months
Key Trial Info
Start Date :
January 29 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05208892
Start Date
January 29 2024
End Date
February 1 2026
Last Update
December 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lucile Packard Childrens Hospital
Palo Alto, California, United States, 94304